Eli Lilly launches new diabetic drug

By Our Corporate Bureau | 04 Oct 2007

1

New Delhi: Eli Lilly has announced the launch of its registered diabetic injection Byetta (exenatide injection) in India.

The drug treats patients with Type2 diabetes, as part of the prescription with two common oral diabetes medications, metformin and / or sulphonylureas.

Exenatide is the first in a new class of anti-diabetic medicines known as incretin mimetics and is the first FDA-approved agent of this category, a company statement quoted Sandeep Gupta, CMD, Lilly India, as saying. The statement hails Byetta as a novel approach to treating type 2 diabetes.

Business History Videos

History of hovercraft Part 3...

Today I shall talk a bit more about the military plans for ...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of hovercraft Part 2...

In this episode of our history of hovercraft, we shall exam...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Hovercraft Part 1...

If you’ve been a James Bond movie fan, you may recall seein...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Trams in India | ...

The video I am presenting to you is based on a script writt...

By Aniket Gupta | Presenter: Sheetal Gaikwad

view more